Evidence map›Paper›PMID 32461290›Full record

ArticleBMJ open2020

Cohort profile: the Australian genetics of depression study.

Enda M Byrne, Katherine M Kirk, Sarah E Medland, John J McGrath, Lucia Colodro-Conde, Richard Parker, Simone Cross, Lenore Sullivan, Dixie J Statham, Douglas F Levinson and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 10 pooled it
3.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 10 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Enda M ByrneInstitute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia enda.byrne@uq.edu.au.ORCID 0000-0002-9491-7797
Katherine M KirkQIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Sarah E MedlandQIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
John J McGrathQueensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia.
Lucia Colodro-CondeQIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Richard ParkerQIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Simone CrossQIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Lenore SullivanQIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Dixie J StathamSchool of Health and Life Sciences, Federation University, Ballarat, Victoria, Australia.
Douglas F LevinsonDepartment of Psychiatry and Behavioural Sciences, Stanford University, Stanford, California, USA.
Julio LicinioDepartment of Psychiatry, State University of New York Upstate Medical University, Syracuse, New York, USA.
Naomi R WrayInstitute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
Ian B HickieBrain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia.
Nicholas G MartinQIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
QIMR Berghofer Medical Research Institute · AUAllen Institute for Brain Science · USFederation University · AUStanford University · USSUNY Upstate Medical University · USThe University of Queensland · AUThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDepression is the most common psychiatric disorder and the largest contributor to global disability. The Australian Genetics of Depression study was established to recruit a large cohort of individuals who have been diagnosed with depression at some point in their lifetime. The purpose of establishing this cohort is to investigate genetic and environmental risk factors for depression and response to commonly prescribed antidepressants.

participantsA total of 20 689 participants were recruited through the Australian Department of Human Services and a media campaign, 75% of whom were female. The average age of participants was 43 years±15 years. Participants completed an online questionnaire that consisted of a compulsory module that assessed self-reported psychiatric history, clinical depression using the Composite Interview Diagnostic Interview Short Form and experiences of using commonly prescribed antidepressants. Further voluntary modules assessed a wide range of traits of relevance to psychopathology. Participants who reported they were willing to provide a DNA sample (75%) were sent a saliva kit in the mail. FINDINGS TO DATE: 95% of participants reported being given a diagnosis of depression by a medical practitioner and 88% met the criteria for a lifetime depressive episode. 68% of the sample report having been diagnosed with another psychiatric disorder in addition to depression. In line with findings from clinical trials, only 33% of the sample report responding well to the first antidepressant they were prescribed. FUTURE PLANS: A number of analyses to investigate the genetic architecture of depression and common comorbidities will be conducted. The cohort will contribute to the global effort to identify genetic variants that increase risk to depression. Furthermore, a thorough investigation of genetic and psychosocial predictors of antidepressant response and side effects is planned.

Indexed as

DepressionMajor Depressive DisorderAdultAntidepressive AgentsAustraliaFemaleHumansMaleSurveys and QuestionnairesAntidepressive Agentsanxiety disordersdepression & mood disordersgenetics

Identifiers

PMID32461290
PMCPMC7259831
OpenAlexW3029801885

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.